EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Leucine-Rich Repeat Kinase 2 (LRRK2) in Glucose Metabolism and Metabolic–Neuroinflammatory Crosstalk

Fumitaka Kawakami iD, Motoki Imai, Masanori Ogata, Toshiya Habata iD, Shun Tamaki iD, Rei Kawashima, Yoshifumi Kurosaki iD, Sayaka Miyai iD, Moragot Chatatikun iD, May Pyone Kyaw, Kenichi Ohba

Biomolecules · 2026

DOI: 10.3390/biom16040588 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Fumitaka Kawakami und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regulation Biochemistry, Graduate School of Medical Sciences, Kitasato University, 1-15-1, Kitasato, Minami-ku, Sagamihara 252-0373, Ka…. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Glucose, Parkinson Disease, Neuroinflammatory Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leucine-rich repeat kinase 2 (LRRK2) is a multidomain serine/threonine kinase and a major genetic contributor to Parkinson’s disease (PD). Although LRRK2 has been extensively studied in neurodegeneration, emerging evidence indicates that it also plays a critical role in systemic metabolism. LRRK2 regulates glucose homeostasis through modulation of insulin signaling, vesicle trafficking, mitochondrial function, and inflammatory responses. Studies using LRRK2 knockout and knock-in models, including the pathogenic G2019S mutation, have revealed abnormalities in insulin sensitivity, adipose tissue inflammation, hepatic glucose production, and skeletal muscle metabolism. Mechanistically, LRRK2 phosphorylates Rab GTPases, thereby controlling insulin receptor trafficking and GLUT4 translocation. In addition, LRRK2 influences mitochondrial dynamics and reactive oxygen species production, linking metabolic stress to inflammatory signaling. Importantly, LRRK2 also regulates innate immune pathways, including TLR4–NFκB signaling and inflammasome activation, thereby connecting peripheral metabolic dysfunction to neuroinflammation. Here, we propose an integrated metabolic–neuroinflammatory crosstalk model in which LRRK2 functions as a molecular coordinator linking peripheral metabolic dysfunction to central neurodegeneration. In this framework, systemic metabolic stress—characterized by insulin resistance, chronic inflammation, advanced glycation end product (AGE) accumulation, and blood–brain barrier disruption—drives microglial activation and neurodegenerative processes. Understanding this systemic axis may provide new therapeutic opportunities targeting both metabolic dysfunction and neurodegeneration in PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2GlucoseParkinson DiseaseNeuroinflammatory DiseasesHumansAnimalsSignal TransductionInflammationInsulin Resistance

Stichwörter der Autor:innen

LRRK2Parkinson’s diseaseRab GTPaseglucose metabolisminflammationinsulin signalingmitochondrial function

Substanzen

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2GlucoseLRRK2 protein, human

Autor:innen und Institutionen

  • Department of Regulation Biochemistry, Graduate School of Medical Sciences, Kitasato University, 1-15-1, Kitasato, Minami-ku, Sagamihara 252-0373, Kanagawa, Japan.
  • Department of Health Administration, School of Allied Health Sciences, Kitasato University, Sagamihara 252-0373, Kanagawa, Japan.
  • Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, Sagamihara 252-0373, Kanagawa, Japan.
  • Department of Molecular Diagnostics, School of Allied Health Sciences, Kitasato University, Sagamihara 252-0373, Kanagawa, Japan.
  • Department of Applied Tumor Pathology, Graduate School of Medical Sciences, Kitasato University, Sagamihara 252-0373, Kanagawa, Japan.
  • Department of Physiology, School of Allied Health Sciences, Kitasato University, Sagamihara 252-0373, Kanagawa, Japan.

ORCID-Profile: Fumitaka Kawakami, Toshiya Habata, Shun Tamaki, Yoshifumi Kurosaki, Sayaka Miyai, Moragot Chatatikun

Förderung

  • Japan Society for the Promotion of Science
  • JSPS KAKENHI

Zitieren

APA

Kawakami, F., Imai, M., Ogata, M., Habata, T., Tamaki, S., Kawashima, R., Kurosaki, Y., Miyai, S., Chatatikun, M., Kyaw, M. P., & Ohba, K. (2026). Leucine-Rich Repeat Kinase 2 (LRRK2) in Glucose Metabolism and Metabolic–Neuroinflammatory Crosstalk. Biomolecules. https://doi.org/10.3390/biom16040588

Vancouver

Kawakami F, Imai M, Ogata M, Habata T, Tamaki S, Kawashima R, et al. Leucine-Rich Repeat Kinase 2 (LRRK2) in Glucose Metabolism and Metabolic–Neuroinflammatory Crosstalk. Biomolecules. 2026. doi:10.3390/biom16040588

BibTeX
@article{Kawakami2026,
  author = {Kawakami, Fumitaka and Imai, Motoki and Ogata, Masanori and Habata, Toshiya and Tamaki, Shun and Kawashima, Rei and Kurosaki, Yoshifumi and Miyai, Sayaka and Chatatikun, Moragot and Kyaw, May Pyone and Ohba, Kenichi},
  title = {Leucine-Rich Repeat Kinase 2 (LRRK2) in Glucose Metabolism and Metabolic–Neuroinflammatory Crosstalk},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16040588}
}
Kostenlos starten →